Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Castello

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Plos One|July 31, 2015
The Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 DiabetesFrancesca Capone, Eliana Guerriero, Giovanni Colonna, et al.
Oxidative Medicine and Cellular Longevity|May 31, 2014
Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategiesGiovanni Pagano, Annarita Aiello Talamanca, Giuseppe Castello, et al.
World Journal of Cardiology|December 17, 2010
Impaired diastolic function in naïve untreated human immunodeficiency virus infected patientsUgo Oliviero, Giovanni Bonadies, Giorgio Bosso, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 30, 2014
Peptides targeting chemokine receptor CXCR4: structural behavior and biological binding studiesSusan Costantini, Raffaele Raucci, Giovanni Colonna, et al.
Molecules (Basel, Switzerland)|February 28, 2013
Evaluation of selenite effects on selenoproteins and cytokinome in human hepatoma cell linesFabiola Rusolo, Biagio Pucci, Giovanni Colonna, et al.
Cancer Immunology, Immunotherapy : CII|April 6, 2007
CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell typeStefania Scala, Caterina Ieranò, Alessandro Ottaiano, et al.
Cytokine|March 7, 2006
Soluble interleukin-2 receptor in stage I-III melanomaAlessandro Ottaiano, Enrico Leonardi, Ester Simeone, et al.
Cancer Immunology, Immunotherapy : CII|December 14, 2004
Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cellsAlessandro Ottaiano, Antonella di Palma, Maria Napolitano, et al.
Journal of Translational Medicine|November 23, 2012
Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcomeRosa Calemma, Alessandro Ottaiano, Anna Maria Trotta, et al.
BMC Cancer|November 17, 2006
Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanomaGiuseppe Palmieri, Sabrina M R Satriano, Mario Budroni, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Plos One|July 31, 2015
The Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 DiabetesFrancesca Capone, Eliana Guerriero, Giovanni Colonna, et al.
Oxidative Medicine and Cellular Longevity|May 31, 2014
Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategiesGiovanni Pagano, Annarita Aiello Talamanca, Giuseppe Castello, et al.
World Journal of Cardiology|December 17, 2010
Impaired diastolic function in naïve untreated human immunodeficiency virus infected patientsUgo Oliviero, Giovanni Bonadies, Giorgio Bosso, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 30, 2014
Peptides targeting chemokine receptor CXCR4: structural behavior and biological binding studiesSusan Costantini, Raffaele Raucci, Giovanni Colonna, et al.
Molecules (Basel, Switzerland)|February 28, 2013
Evaluation of selenite effects on selenoproteins and cytokinome in human hepatoma cell linesFabiola Rusolo, Biagio Pucci, Giovanni Colonna, et al.
Cancer Immunology, Immunotherapy : CII|April 6, 2007
CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell typeStefania Scala, Caterina Ieranò, Alessandro Ottaiano, et al.
Cytokine|March 7, 2006
Soluble interleukin-2 receptor in stage I-III melanomaAlessandro Ottaiano, Enrico Leonardi, Ester Simeone, et al.
Cancer Immunology, Immunotherapy : CII|December 14, 2004
Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cellsAlessandro Ottaiano, Antonella di Palma, Maria Napolitano, et al.
Journal of Translational Medicine|November 23, 2012
Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcomeRosa Calemma, Alessandro Ottaiano, Anna Maria Trotta, et al.
BMC Cancer|November 17, 2006
Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanomaGiuseppe Palmieri, Sabrina M R Satriano, Mario Budroni, et al.
Pageof 9